One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v126.23.5142.5142
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
Affiliation: The University of Texas MD Anderson Cancer Center, Hôpital Lyon Sud, Huntsman Cancer Institute, University of Utah, Centre Hospitalier Universitaire de Poitiers, Inserm, Ariadne Diagnostics (United States), University of California, Los Angeles, Ronald Reagan UCLA Medical Center, Imperial College Healthcare NHS Trust, Hammersmith Hospital, University of Bologna, Dana-Farber Cancer Institute, St. Eugenio Hospital, Hôpital Saint-Louis, Moffitt Cancer Center, Seoul St. Mary's Hospital, Catholic University of Korea, Heidelberg University, University Hospital Heidelberg, University of Milano-Bicocca, Azienda Ospedaliera San Gerardo, Charité - Universitätsmedizin Berlin, Emory University, South Australian Health and Medical Research Institute, South Australia Pathology, University of Adelaide, Singapore General Hospital, Michigan Center for Translational Pathology, University of Michigan–Ann Arbor, Jena University HospitalEvaluation of the Benefit/Risk Profile of Ponatinib in CP-CML Patients over Time: 4-Year Follow-up of the Phase 2 PACE Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
